218 related articles for article (PubMed ID: 22041773)
1. [The effect of cyclophosphamide on cytokines in patients with primary Sjögren's syndrome-associated interstitial lung disease].
Mo HY; Wang LF; Xu J; Shi YH; Yang M; Zhou RH
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jul; 34(7):495-9. PubMed ID: 22041773
[TBL] [Abstract][Full Text] [Related]
2. Effect of cyclophosphamide on cytokines in patients with primary Sjögren's syndrome-associated interstitial lung disease in South China.
Zhang L; Mo H; Zhu M; Wang L
Rheumatol Int; 2013 Jun; 33(6):1403-7. PubMed ID: 23143555
[TBL] [Abstract][Full Text] [Related]
3. B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome.
Ittah M; Miceli-Richard C; Eric Gottenberg J; Lavie F; Lazure T; Ba N; Sellam J; Lepajolec C; Mariette X
Arthritis Res Ther; 2006; 8(2):R51. PubMed ID: 16507175
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary manifestations of Sjögren's syndrome.
Shi JH; Liu HR; Xu WB; Feng RE; Zhang ZH; Tian XL; Zhu YJ
Respiration; 2009; 78(4):377-86. PubMed ID: 19390161
[TBL] [Abstract][Full Text] [Related]
5. [The serum levels of cytokines in patients with rheumatoid arthritis associated interstitial lung disease and their clinical significance].
Ji YX; Huang JA; Zong JP; Lü DF; Xin XF; He J; Chen Y; Chen XH; Yu SP; Li JL
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Apr; 31(4):264-7. PubMed ID: 18846962
[TBL] [Abstract][Full Text] [Related]
6. [Clinical observation of rheumatoid arthritis associated interstitial lung disease patients and changes of serum cytokines thereof].
Jian XD; Guo GR; Ruan YJ; Zhao B; Wang YC; Ning Q; Zhang YC
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(27):1884-7. PubMed ID: 19039999
[TBL] [Abstract][Full Text] [Related]
7. Increased levels of serum galectin-3 in patients with primary Sjögren's syndrome: associated with interstitial lung disease.
Zhang R; Sun T; Song L; Zuo D; Xiao W
Cytokine; 2014 Oct; 69(2):289-93. PubMed ID: 24981072
[TBL] [Abstract][Full Text] [Related]
8. Increase in the ratio of matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 in saliva from patients with primary Sjögren's syndrome.
Asatsuma M; Ito S; Watanabe M; Takeishi H; Nomura S; Wada Y; Nakano M; Gejyo F; Igarashi A
Clin Chim Acta; 2004 Jul; 345(1-2):99-104. PubMed ID: 15193983
[TBL] [Abstract][Full Text] [Related]
9. Angiopoietin-like protein 2 as a novel marker for patients with primary Sjogren's syndrome-related interstitial lung disease.
Shi L; Fu Q; Chen N; Liu R; Zheng Y
Clin Exp Med; 2020 Aug; 20(3):393-399. PubMed ID: 32253547
[TBL] [Abstract][Full Text] [Related]
10. Cytokine gene polymorphisms and BALF cytokine levels in interstitial lung diseases.
Vasakova M; Sterclova M; Kolesar L; Slavcev A; Pohunek P; Sulc J; Striz I
Respir Med; 2009 May; 103(5):773-9. PubMed ID: 19117745
[TBL] [Abstract][Full Text] [Related]
11. [Interactions of ovarian carcinoma cells and human peritoneal mesothelial cells involved in matrix metalloproteinases expressions of ovarian carcinoma cells].
Zhang JJ; Wang B
Zhonghua Fu Chan Ke Za Zhi; 2006 Mar; 41(3):194-7. PubMed ID: 16640888
[TBL] [Abstract][Full Text] [Related]
12. Interstitial lung disease in primary Sjögren's syndrome.
Roca F; Dominique S; Schmidt J; Smail A; Duhaut P; Lévesque H; Marie I
Autoimmun Rev; 2017 Jan; 16(1):48-54. PubMed ID: 27682894
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-β1 suppresses the up-regulation of matrix metalloproteinase-2 by lung fibroblasts in response to tumor necrosis factor-α.
Ye H; Cai PC; Zhou Q; Ma WL
Wound Repair Regen; 2011; 19(3):392-9. PubMed ID: 21518085
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of patients with primary Sjögren's syndrome associated interstitial lung disease and relevant features of disease progression.
Zhang T; Yuan F; Xu L; Sun W; Liu L; Xue J
Clin Rheumatol; 2020 May; 39(5):1561-1568. PubMed ID: 31902032
[TBL] [Abstract][Full Text] [Related]
15. [Effects of andrographolide on the concentration of cytokines in BALF and the expressions of type I and III collagen mRNA in lung tissue in bleomycin-induced rat pulmonary fibrosis].
Zhu HL; Huang CL; Wang WJ; Zhan XQ; Fan XM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul; 27(7):725-9. PubMed ID: 21722520
[TBL] [Abstract][Full Text] [Related]
16. Potential contribution of interleukin-33 to the development of interstitial lung disease in patients with primary Sjogren's Syndrome.
Zhao L; Yao L; Yuan L; Xia L; Shen H; Lu J
Cytokine; 2013 Oct; 64(1):22-4. PubMed ID: 23910012
[TBL] [Abstract][Full Text] [Related]
17. Association between IFN-alpha and primary Sjogren's syndrome.
Zheng L; Zhang Z; Yu C; Tu L; Zhong L; Yang C
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Jan; 107(1):e12-8. PubMed ID: 19101478
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome.
Yoon KC; Jeong IY; Park YG; Yang SY
Cornea; 2007 May; 26(4):431-7. PubMed ID: 17457192
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for progression and prognosis of primary Sjögren's syndrome-associated interstitial lung disease in a Chinese population.
Xu Y; Zhou J; Dong X; Guo X; Lu Y; Zheng Y
Int J Rheum Dis; 2020 Dec; 23(12):1734-1740. PubMed ID: 33226736
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers of interstitial lung disease associated with primary Sjögren's syndrome.
Weng L; Chen Y; Liang T; Lin Y; Liu D; Yu C; Hu Y; Lui W; Liu Y; Chen X; Li Q; Ge S; Ascherman DP; Chen J
Eur J Med Res; 2022 Oct; 27(1):199. PubMed ID: 36217184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
